Voriconazole: A second-generation triazole

P. H. Chandrasekar, E. Manavathu

Research output: Contribution to journalReview articlepeer-review

99 Scopus citations


Voriconazole, a derivative of fluconazole, is an antifungal triazole with expanded spectrum of activity against a variety of yeasts and filamentous fungi. It exhibits fungicidal activity against Aspergillus species. Preliminary data from animal models and clinical trials show promise in the treatment of candidiasis and aspergillosis. Of concern is the development of resistance to voriconazole and cross-resistance with other azoles. Voriconazole is a welcome addition to our limited armamentarium against potentially fatal fungal infections.

Original languageEnglish (US)
Pages (from-to)135-148
Number of pages14
JournalDrugs of Today
Issue number2
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Voriconazole: A second-generation triazole'. Together they form a unique fingerprint.

Cite this